Contact Us   |   Sign In   |   Join CAHR
Market Access 101 - April 30, 2018
Share |

Market Access 101: Fundamentals of Reimbursement in Canada

Monday, April 30, 2018
Hilton Meadowvale/Mississauga

Who Should Attend? Professionals in Market Access, Pharmaceutical Policy, Marketing and Sales who are interested in learning more about Market Access as well as pharmaceutical industry professionals who work with Market Access.

We will explore the market access decision-making pathway for pharmaceuticals from Health Canada approval through reimbursement in private and public drug plans. Attendees will gain insights into the various steps and the inter-relationships between each milestone of pharmaceutical market access. The sessions will also address the interests and involvement of various perspectives and stakeholders, including public payers, private payers, health technology assessment reviewers, regulatory agencies, pricing agencies, manufacturers and patients.

We will also be focusing on networking, market access career discussions, and stakeholder communications during a lunch-hour workshop that will explore how you connect with others in the Market Access environment.

If you are someone who wants to learn more about market access, then consider joining us; if you are seeking your Market Access Certification through our CMAP program this is a must-attend event!







9:00am Welcome & Introduction - Angela Rocchi (Athena Research)
  • Deciphering headlines

Clinical Evidence - Lorraine Boyle (Case Market Access Consulting)

  • Market Access perspectives on clinical evidence
10:00am Health Technology Assessment  - Matthew Brougham (Brougham Consulting)
  • Orientation to Canada's centralized HTA agencies



11:00am Submissions - Ferg Mills (Innomar Strategies)
  • Defining the submission components: clinical summaries,economic evaluations, budget impact analysis


  • Guest Speaker: Bill Dempster (3Sixty Public Affairs)
    Knowing Your Stuff is Not Enough - What you really need is communication skills

National Pharmacare - Bill Dempster (3Sixty Public Affairs)

  • How our world might change
1:15pm Patented Medicines Prices Review Board - Joan McCormick (IQVIA)
  • The current and future structures of the PMPRB



2:30pm Pan-Canadian Pharmaceutical Alliance - Brad Alyward (Morse Consulting)
  • What the PCPA has achieved and how
3:15pm Private Payers - Rebecca Szilagyi-Vieira (GlaxoSmithKline)
  • The distinct perspective of the private payer world: a shifting landscape.

Closing Remarks - Program Ends


CAHR reserves the right to cancel or change speakers, content and date without prior notice. We assume no liability for these changes.

 Thank you to our event partners!


For more information, contact Amanda at 416-494-1440 or email 


Membership Software Powered by YourMembership  ::  Legal